After treatment

What cancer treatment does to your body

Treatment works by causing damage in a controlled way. Understanding what it left behind is the first step in doing something about it.

The conversation about side effects usually happens before treatment, when you are frightened and taking in almost nothing, and rarely happens again afterwards. By the time you are ready to ask what actually happened to your body, the appointments have stopped.

So, plainly: here is what each part of treatment does, and what it tends to leave behind.

Chemotherapy

Chemotherapy targets rapidly dividing cells. That is the mechanism — and cancer cells are not the only rapidly dividing cells in your body. Gut lining, hair follicles, bone marrow and immune cells all divide quickly, and all take the hit.

After chemotherapy, white blood cell count is suppressed, the gut microbiome is disrupted, the liver has spent months processing cytotoxic drugs, and glutathione reserves — central to your body’s antioxidant defence — are depleted.

There is also the part that rarely gets named as a side effect: the steroids given alongside chemotherapy commonly drive appetite and weight gain, on top of the metabolic disruption from treatment itself.

Most people finish treatment heavier than they started, and are then discharged into a world that treats the result as a willpower problem.

It is a pharmacological effect, not a character flaw. It is also measurable, which is more useful than either guilt or reassurance.

Radiation

Radiation damages DNA in the target area — both cancer and healthy tissue. What it leaves behind is localised inflammation, fibrosis, and potential damage to lymphatic and blood vessels in the field.

Fibrosis is the one with the longest tail. Scar tissue makes fascia stiff and restrictive, and because lymphatic vessels run through fascia, stiffened tissue physically compresses the channels underneath it. The restriction is mechanical, which is why movement and fascia work make a difference to it.

Surgery and lymph node removal

Surgery is the part with permanent structural consequences. Every node removed is a junction closed for good in your lymphatic network, and the remaining nodes must compensate for a territory they did not previously serve.

Lymphoedema risk after node removal is lifelong rather than temporary. It does not expire at five years, and it is worth understanding the system properly rather than just watching your arm nervously.

Hormone therapy

Tamoxifen and aromatase inhibitors deliberately suppress oestrogen, which is the point of them. The trade-off is a set of effects that run for years rather than months: joint pain, bone density loss, weight gain, mood changes and hot flushes.

Bone density loss is the one to take seriously early, because it is silent until it is not, and because weight-bearing exercise is one of the few things that pushes back against it.

The parts that don’t show up on a scan

Fatigue is the most common complaint after treatment ends and the least well handled. It is not ordinary tiredness and it does not reliably resolve with rest. It can persist for months or years, and because there is no test for it, it tends to go unrecorded — which makes it very hard to tell whether anything you try is working.

The same applies to sleep disruption, concentration and memory changes, and the low-grade sense that your body is not behaving the way it used to. None of it appears in a discharge summary.

These are the symptoms most likely to be met with “it takes time” — which is true, and also unsatisfying when nobody is measuring whether the time is doing anything.

Why it ends without a plan

The end of treatment is an administrative event more than a physiological one. Your appointments stop because the protocol you were on has finished, not because your body has returned to where it started.

So you are discharged carrying every change listed above, into a world that reasonably assumes you are now fine. Friends stop asking. Work resumes. And the follow-up that does exist is watching for the disease coming back — which matters enormously, and which is a completely different question from how you are actually doing.

What all of this adds up to

A body with suppressed immune function, a disrupted gut, a liver that has worked hard, depleted antioxidant reserves, stiffened connective tissue, a structurally altered lymphatic system, altered hormones, and often reduced bone density and increased fat mass.

None of that is a reason for despair. It is a description of a starting point — and almost every item on that list is responsive to inputs you control.

Why a baseline matters more than a plan

Every one of those changes is measurable. Inflammation, immune markers, liver function, vitamin status, bone turnover, body composition. Which means the honest question after treatment is not “what should I do” — there is no shortage of people willing to answer that — but “what did it do, and how would I know?”

During treatment, your team baselined you to measure what the drugs might do to you. The same method, turned around, measures what you do for yourself.